Medical studies are often inconclusive, but even the smallest advancements can prove invaluable for humanity. AstraZeneca seems to have found a way to tackle lung cancer with the help of a newly developed combination of drugs. Tests are still inconclusive, but medics are optimistic because it seems that the new drugs will also boost the immune system. After having avoided a multi-billion dollar … [Read more...]
FDA gives green signal to Novartis’s ‘Zykadia’ to treat lung cancer
The U.S. Food and Drug Administration has give its green signal to Novartis's new therapy drug 'Zykadia'(ceritinib) to treat a certain type of late stag non-small cell lung cancer (NSCLC). The early approval comes as a surprise as FDA was expected to finish reviewing the drug application by August 24, 2014 and then pronounce its verdict. Zykadia is the fourth drug with breakthrough … [Read more...]